SCHEMBL19882134

SCHEMBL19882134

CCN(Cc1cc(C(C)=O)ccc1OC)C(=O)CNC(=O)NCc1ccc(NC)cc1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ HTT P42858 2/20 0.41
▸ PPID Q08752 1/20 0.41
▸ NAMPT P43490 3/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ MCHR1 Q99705 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MITF O75030 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2035440 0.90 PPIB (0.49) ALDH1A1MEN1KMT2AHTTPPID
SCHEMBL12643833 0.80 PPIB (0.46) ALDH1A1MEN1KMT2AHTTPPID
SCHEMBL19882131 0.80 PPIB (0.53) MEN1KMT2AHTTPPIDL3MBTL1
SCHEMBL19882147 0.79 TSPO (0.53) ALDH1A1MEN1KMT2AHTTSMN1; SMN2
SCHEMBL2037947 0.76 PPIB (0.62) ALDH1A1MEN1KMT2AHTTPPID
SCHEMBL2041992 0.71 PPIB (0.51) ALDH1A1MEN1KMT2AHTTPPID
SCHEMBL12643831 0.71 PPIB (0.51) ALDH1A1MEN1KMT2AHTTPPID
SCHEMBL2040991 0.68 PPIB (0.69) ALDH1A1MEN1KMT2AHTTPPID
SCHEMBL334398 0.68 ALDH1A1 (0.70) ALDH1A1MEN1KMT2AHTTL3MBTL1
SCHEMBL2038255 0.67 PPIB (0.58) ALDH1A1MEN1KMT2AHTTPPID

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516387-B1 INHIBITORS OF CYCLOPHILINS FOR USE IN THE PREVENTION AND/OR THE TREATMENT OF VIRAL PATHOLOGIES OR INFECTIONS INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE (INSERM) (FR) 2018-02-21 — — EP disclosed
Send feedback